National Cancer Institute

Current Therapy for Mesothelioma
 

New Drug for Mesothelioma 
 
http://www.medicalnewstoday.com/medicalnews.php?newsid=7499
  

Mesothelioma Reporter
 
http://www.mesotheliomareporter.org 
 

References

1. Briselli M, Mark EJ, Dickersin GR. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer. 1981;47:26782689.

2. Antman KH, Pass HI, DeLaney T, et al. Benign and malignant mesothelioma. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. 4th ed. Philadelphia, Pa: JB Lippincott Co; 1993:14891508. 

3. Rusch VW. Diffuse malignant mesothelioma. In: Shields TW, ed. General Thoracic Surgery. 4th ed. Baltimore, Md: Williams & Wilkins; 1994:731747. 

4. Pass HI, Kennedy RC, Carbone M. Evidence for and implications of SV40like sequences in human mesotheliomas. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology 1996. Philadelphia, Pa: LippincottRaven; 1996:89108.

5. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40like DNA sequences in human pleural mesothelioma. Oncogene. 1994;9:1781 1790. 

6. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol. 1993;142:15241533. 

7. Enterline PE, Henderson VL. Geographic patterns for pleural mesothelioma deaths in the United States, 196881. J Natl Cancer Inst. 1987;79:3137. 

8. Connelly RR, Spirtas R, Myers MH, et al. Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst. 1987;78:10531060. 

9. Walker AM, Loughlin JE, Friedlander ER, et al. Projections of asbestosrelated disease 19802009. J Occup Med. 1983;25:409425. 

10. Olesen LL, Thorshauge H. Thrombocytosis in patients with malignant pleural mesothelioma. Cancer. 1988;62:11941196. 

11. Patz EF Jr, Shaffer K, PiwnicaWorms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol. 1992;159:961966. 

12. Sugarbaker DJ, Strauss GM, Lynch TJ, et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol. 1993;11:11721178.

13. Sugarbaker DJ, Garcia JP, Richards WG, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg. 1996;224:288294.

14. Sugarbaker DJ, Reed MF, Swanson SJ. Mesothelioma. In: Sabiston DC Jr, ed. Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 15th ed. Philadelphia, Pa: WB Saunders Co; 1996: 1876-1883. 

15. Butchart EG, Ashcroft T, Barnsley WC, et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax. 1976;31:1524. 

16. Chahinian AP. Therapeutic modalities in malignant pleural mesothelioma. In: Chretien J, Hirsch A, eds. Diseases of the Pleura. New York, NY: Masson Publishers; 1983.

17. Rusch VW, Ginsberg RJ. New concepts in the staging of mesotheliomas. In: Deslauriers J, Lacquet LK, eds. Thoracic Surgery: Surgical Management of Pleural Diseases. St. Louis, Mo: Mosby Year-Book; 1990:3340. 

18. Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma: from the International Mesothelioma Interest Group. Chest. 1995;108:11221128. 

19. Gordon W Jr, Antman KH, Greenberger JS, et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys. 1982;8:1925.

20. Eschwege F, Schlienger M. Radiotherapy of malignant pleural mesotheliomas: apropos of 14 cases irradiated at high doses. J Radiol Electrol Med Nucl. 1973;54:255259. 

21. Sugarbaker DJ, Jaklitsch MT, Soutter AD, et al. Multimodality therapy of malignant mesothelioma. In: Roth JA, Ruckdeschel JC, Weisenburger TH, eds. Thoracic Oncology. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1996:538555. 

22. Worn H. Moglichkeiten und ergebnisse der chirurgischen behandlung des malignen pleuramesotheliomas. (Chances and results of surgery of malignant mesothelioma of the pleura [author's trans].) Thoraxchir Vask Chir. 1974;22:391393.

23. Allen KB, Faber LP, Warren WH. Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy. Chest Surg Clin North Am. 1994;4:113126. 

24. Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1996;111:815825.

25. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: a Lung Cancer Study Group trial. J Thorac Cardiovasc Surg. 1991;102:19.

26. Rusch V, Saltz L, Venkatraman E, et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol. 1994;12:11561163. 

27. Garcia JP, Richards WG, Sugarbaker DJ. Surgical treatment of malignant mesothelioma. In: Kaiser LR, Kron IL, Spray TL, eds. Mastery of Cardiothoracic Surgery. Philadelphia, Pa: LippincottRaven; 1997. 

28. Hoffman KR. Paclitaxel and carboplatin combination chemotherapy as an effective palliative treatment for malignant mesothelioma. Proc Annu Meet Am Soc Clin Oncol. 1996;15:A1428.